Billiontoone Inc (BLLN) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Billiontoone Inc   (NASDAQ: BLLN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Select the Financial Report: Select the Period:


Description of Billiontoone Inc's Business Segments
The company operates as a single operating and reportable segment. The Chief Executive Officer, serving as the Chief Operating Decision Maker (CODM), reviews company-wide financial information to allocate resources and evaluate performance. Key financial metrics considered include cash used in operations, revenue, gross margin, and net income (loss), with net income (loss) serving as the segment's measure of profitability. The company's revenues are derived from prenatal and oncology testing services provided to patients, utilizing its proprietary molecular diagnostic technology platform. The majority of the company's customers and long-lived assets are located in the United States. The technology platform is applied consistently across both prenatal and oncology testing services.

Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Composition of Billiontoone Inc Revenues by Segments
 
Prenatal    89.3 % of total Revenue
Oncology    9.92 % of total Revenue
Clinical trial support and other services    1.06 % of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)		 %
(of total Revenues)
Prenatal 96.53 89.3 %
Oncology 10.72 9.92 %
Clinical trial support and other services 1.14 1.06 %
Total 108.10 100 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%		 Q/Q Revenue
%
Prenatal 72.13 % -
Oncology 392.42 % -
Clinical trial support and other services 60.99 % -
Total - -64.5 %




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)		 %
(Profit Margin)
Total 17.97 16.62 %




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%		 Q/Q Income
%
Total - 515.62 %




Annual Report on Billiontoone Inc Divisions, Sales by Country

 
Prenatal   Prenatal Segment contribution to total sales 91.02 % of total Revenue
Oncology   Oncology Segment contribution to total sales 8.2 % of total Revenue
Clinical trial support and other services   Clinical trial support and other services Segment contribution to total sales 1 % of total Revenue


Twelve months ended 2025
BLLN s Annual Revenue by Geography and Business Segments Sales
(in millions $)		 %
(of total Sales)
Prenatal 277.11 91.02 %
Oncology 24.95 8.2 %
Clinical trial support and other services 3.05 1 %
Total 304.46 100 %


Twelve months ended 2025
BLLN s Annual Income by Country and Business Segments Income
(in millions $)		 %
(Profit Margin)
Total 2.92 0.96 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Prenatal 89.93 % -
Oncology 747.59 % -
Clinical trial support and other services -18.28 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.